Introduction
Riboflavin (vitamin B2, RF), an essential micronutrient exerts its role as coenzymic flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD) via sequential redox reactions within the cell that drives intermediary metabolism of carbohydrates, amino acids, and lipids. Given the fundamental role of this water-soluble vitamin in cellular metabolism, its absorption into the cell solely from dietary sources has generated considerable interest.
Previously, our laboratory identified receptor-mediated endocytic events in RF internalization in human intestinal and placental cells (Huang and Swaan, 2000; Huang and Swaan, 2001 ).
Trafficking upon entry into the cell has been well-characterized and visualized using biochemical and microscopic approaches (Huang et al., 2003) . However, the identity of this vitamin transport system specific to ligand recognition at the cell surface, its binding, and subsequent internalization all remain undefined.
Riboflavin binds non-specifically to plasma proteins (albumin, globulins, and fibrinogen) (Combs, 1998 ) but analogous to other vitamins, such as retinol, vitamin D, and folate (Corrocher et al., 1991; Gomme and Bertolini, 2004; Zanotti and Berni, 2004) it exhibits specific binding to riboflavin carrier proteins (RCPs). Specific RCPs have been identified in the plasma of the laying hen, cow, mice, rats, spadefoot toad, turtle, bonnet monkey and human umbilical cord serum (Foraker et al., 2003) However till date, the molecular identity of this carrier protein remains undetermined. The increased gestational need for RF is pivotal to embryonic growth and development as evaluated in avian (Clagett, 1971) and rodent (Natraj et al., 1987 ) models and stipulates the pregnancy-specific role of hormonally regulated RCPs in RF delivery to the fetus.
(Murthy and Adiga, 1978a; Murthy and Adiga, 1978b; Visweswariah and Adiga, 1988) . . Avian riboflavin carrier protein (chicken RCP; cRCP), the first RCP to be isolated and characterized, is an estrogen-inducible phosphoglycoprotein (37 kDa) that regulates oocyte transport of scavenged RF (Rhodes et al., 1959) . Immunologically, RCPs maintain a degree of inter-species homology since several conformation-dependent monoclonal antibodies raised against the avian protein have been found to cross-react with simian (Visweswariah et al., 1987) , rodent (Subramanian and Adiga, 1996) , and human (Prasad et al., 1992; Subramanian and Adiga, 1999) RCPs. Given this cross-reactivity, and the mammalian taxonomy of this evolutionarily conserved vitamin carrier (Muniyappa and Adiga, 1980b; Muniyappa and Adiga, 1980a; MacLachlan et al., 1993) , the existence and role of a human RCP in mediating RF binding and translocation across the feto-placental membrane barrier seems reasonable.
The working hypothesis describing cellular internalization of RF proposes its sequestration by RCP, recognition by membrane receptors, and uptake via clathrin-coated pits (Mac Lachlan et al., 1994; Huang et al., 2003) . Attempts to identify cRCP receptors have revealed Ca 2+ -dependent binding to members of the low-density lipoprotein (LDL) family of receptors in association with vitellogenin, a broad-specificity carrier (Adiga et al., 1997) . The present study uses mammalian cell lines (BeWo and COS-1) in parallel with avian controls (LMH/2A) to better understand the involvement of RCP in receptor-mediated RF internalization and its fate thereafter. Our combined data demonstrate that RCP translocates across cellular barriers bringing with it bound ligand (RF) before recycling back to the extracellular milieu.
Understanding this system may serve as a novel platform that could be targeted clinically towards cells with enhanced nutritional requirements for RF, such as the fetus and breast tumors.
Materials and Methods

Cell Culture
The protein A-purified chicken riboflavin carrier protein (cRCP) antisera (20 -200 µg/ml), and preimmune rabbit sera (200 µg/ml). All solutions were prepared in Hanks' balanced salt solution (HBSS, pH 7.4) containing 25 mM glucose and 10 mM HEPES. After incubation, cells were processed as previously described (Huang and Swaan, 2001 rpm for 2 min. The HAP pellet was washed with Tris buffer (pH 7.2), and bound radiolabelassociated protein released using ethanol following centrifugation at 14,000 rpm for 3 min.
Results were expressed as % total radioactivity. 
Expression and Binding of Chicken Riboflavin Carrier Protein in Transfected Cells
Immunofluorescence Microscopy
BeWo and COS-1 cells, transfected with cRCP, were grown on 4-well culture slides (Becton Dickinson, Bedford, MA) and processed for immunostaining as previously described (Huang et al., 2003 the presence of 0 -1 µM unlabeled cRCP and 2 -25 µM monensin at 37 °C. After 20 min, cells were processed as described above. Kinetic parameters were determined by nonlinear regression analysis using the following equation (Prism 4.0, Graph Pad Software Inc., San Diego, CA).
where V represents the velocity of carrier-mediated uptake, V max the maximum transport °C. After internalization, cells were washed three times with DPBS, pH 7.4 and pH 3.0 to remove non-specific and membrane bound radioactivity. Fresh media containing unlabeled cRCP was added to each well and maintained at 4 °C, 16 °C, or 37 °C. Aliquots from the extracellular media were taken at regular intervals up to 1 hr and replacement buffer was added.
After an hour, cells were washed thoroughly, lysed and processed as described above to determine intracellular cRCP accumulation. Recycling half-life (t 1/2 ) was determined using first order kinetics (equation 2; Prism 4.0, Graph Pad Software Inc., San Diego, CA).
where k is the recycling rate constant.
Ligand Uptake and Subcellular Fractionation
Cell monolayers were dosed with 10 nM each of Fractions were identified by western blot analyses using organelle-specific protein markers (endosomal fractions were identified using clathrin and Rab5 GTPase antibodies; lysosomes were detected using lysosome-associated protein 1 (LAMP-1) antibody; BD Pharmingen, San Diego, CA) Fractionated proteins were resolved on 7.5% or 18% Tris-HCl gels, transferred to PVDF membranes (Immun-Blot™, Bio-Rad, Hercules, CA), immunoblotted using peroxidase-conjugated secondary antibodies, and detected using the ECL plus system (Amersham Biosciences, Piscataway, NJ).
Data Analysis
All experiments were carried out in triplicate and repeated with at least two different cell populations. Results are expressed as mean ± S.D. Statistical analyses between the treatments and their respective controls were performed using one-way ANOVA followed by the Student Newman-Keuls post-test with significance at p < 0.05.
Results
Presence of specific RCP involved in riboflavin uptake
The presence of a mammalian carrier protein that facilitates RF uptake across membrane barriers has been alluded to previously (Merrill et al., 1979; Muniyappa and Adiga, 1980a; Visweswariah and Adiga, 1987b; Visweswariah and Adiga, 1987a; Natraj et al., 1988) although its identity remains inconclusive. Given the suggested inter-species homology of this binding protein, human placental trophoblasts (BeWo) were treated with rabbit anti-chicken riboflavin carrier protein (anti-cRCP) to evaluate incidence and dependence of RF internalization on a specific and homologous protein recognized by the antisera. Treatment of the cells with anticRCP revealed a significant reduction in placental RF uptake (~95%) that occurred even at the lowest concentration of antibody ( Figure 1A ). This indicates that RF internalization may depend on a specific mammalian protein that shares homology with its avian counterpart but is possibly poorly expressed and tightly regulated to influence ligand uptake in human trophoblasts. These findings were supported by visualization of anti-cRCP immunoreactive protein(s) detected only under permeablizing condition within the cellular compartment ( Figure 1D ). Failure to detect signal under non-permeablizing conditions ( Figure 1D ), together with the inhibition of RF uptake ( Figure 1A ) suggests that mammalian cRCP is likely a secreted protein that is released in response to a ligand-triggered stimulus. Specificity of this inhibition with anti-cRCP was established using preimmune rabbit IgG and BSA as controls ( Figure 1A ) while ligand specificity was confirmed by the limited inhibitory effect of anti-cRCP directly on RF uptake ( Figure 1C ) with undetectable changes in intracellular folate accumulation ( Figure 1B ). Unlike RF, the large excess of unlabeled folate showed sub-maximal inhibition of the labeled ligand, possibly due to the presence of multiple components that contribute to its internalization, namely the high capacity folate carrier and high affinity folate binding protein, respectively (Sirotnak and Tolner, 1999 ).
Next we examined the extent of RF binding directly with anti-cRCP to determine if the resultant abrogation in its uptake was due to non-specific protein sequestration. Antibodies were equilibrated with [ 3 H]-RF at 37 °C for 10 min, protein adsorbed using hydroxyapatite, and protein-associated ligand then eluted with ethanol. Figure 1C illustrates that RF binds minimally to anti-cRCP and the non-specific control, BSA, under these conditions. However, binding studies with the known ligand, cRCP, exhibited ~ 45 % of protein-associated ligand, thus substantiating RF recognition for cRCP but not anti-cRCP. This further lends support to the existence and proposed role of a mammalian RCP homologous to the avian form that mediates RF uptake in human placental trophoblasts.
Recognition and binding of cRCP and RF post-transfection in COS-1 cells
BeWo cells express endogenous RCP that contributes to RF absorption when presented in the extracellular media (data not shown). In order to validate these results, another mammalian cell line, COS-1 (kidney cell line from Green African monkey), was selected for its lack of expression of endogenous RCP. Immunofluorescence microscopy was carried out to ascertain detectable levels of RCP upon transfection with cRCP and cRCP-GFP vectors (Figure 2A ).
Functional relevance of these transfections with the secretory RCP was measured using media binding assays to detect RF-specific interactions in spent culture media. Figure 2B shows that COS-1 cells transfected with cRCP or the GFP-cRCP fusion construct exhibited RF-specific binding as indicated by significant differences between total and non-specific binding when excess unlabeled RF was added. These results thereby suggest that mammalian cells secrete a RCP-like protein into the extracellular environment which binds and sequesters RF prior to its internalization. Although the cellular accumulation of RF was not enhanced by cRCP in these studies, based on previous results (Figure 1) we cannot exclude the possibility that this mammalian cRCP-like protein aids in ligand uptake.
cRCP traverses the plasma membrane to mediate internalization of associated cargo
Riboflavin interacts with a specific carrier protein to facilitate its cellular entry but the mechanism that aids ligand uptake upon association remains unknown. Binding and uptake assays were carried out using radiolabeled cRCP in its apo-form (without bound RF) to (Table 1) . However, the maximal transport capacity was approximately three-fold higher in hepatoma cells (V max 75.14 ± 7.6 pmol/mg protein/min) as compared to placental trophoblasts (V max 28.56 ± 2.7 pmol/mg protein/min) suggesting differences in endogenous RCP expression and RF-RCP membrane interaction or increased distribution of unidentified RCP cell surface receptors in the liver. Immunoblot analysis of the cell lysate following cRCP uptake revealed a protein band at ~ 37 kDa which compared with the pure protein ( Figure 3C ). Consequently, binding of RF to cRCP may drive the entry of this ligand-protein complex into the intracellular domain, where we propose RF dissociates from the carrier protein to mediate its downstream metabolic effects.
Intracellular translocation of cRCP via an endocytic pathway
Previous studies from our laboratory propose endocytic events in the translocation process of RF (Huang and Swaan, 2000; Huang and Swaan, 2001; Huang et al., 2003) . In addition, data from the current study suggest that RF crosses the plasma membrane bound to its carrier protein; hence, to further delineate its cellular trafficking, we evaluated the subcellular distribution profile of this internalized protein.
Cells were co-incubated with [ 125 I]-cRCP and [ 3 H]-RF and localization of the dual labels
within the cell were assessed via fractionation based on organelle-specific densities. Given the relative densities of the organelles of the endocytic system (i.e., endosomes and lysosomes), only non-nuclear fractions were considered to be relevant. Distribution profiles for RF and cRCP in native LMH/2A ( Figure 4A ) cells reveal colocalization of the radiolabeled ligands within fractions that were identified using unique organelle-descriptive markers. Colocalization of 
Recycling events of cRCP
Our findings thus far implicate cRCP in ligand recognition and translocation across the plasma membrane via the hypothesized RF receptor-mediated pathway. As previously indicated, the RF carrier protein is degraded within the lysosomal compartments. However, some protein that escapes lysosomal degradation may recycle back to the surface to follow a retroendocytic mode of transport. To further examine if the internalized carrier undergoes retroendocytosis, recycled amounts of [ 125 I]-cRCP were measured over time and as a function of temperature.
Figure 5B shows that at the physiologically relevant temperature of 37 °C, 7.12 ± 0.01 pmol of the internalized cRCP recycled back to the outside constituting ~ 70 % of the cellular load.
Experimental half-life was calculated at 0.97 ± 0.11 min using equation 2. The amount recycled decreased significantly at the quiescent temperature of 4 °C, where only 0.20 ± 0.04 pmol of the cell-loaded cRCP was detected extracellularly after 60 min with a calculated t 1/2 of 2.37 ± 0.39 min. At ambient temperatures of 16 -20 °C, previously reported to inhibit lysosomal trafficking (Apodaca et al., 1994; Ellinger et al., 2001 ), 4.90 ± 0.36 pmol of cRCP was recycled at a t 1/2 of 5.18 ± 0.04 min. These data indicate that although RCP is partially degraded within the cell, some of it is recovered back to the extracellular environment for its continued role in RF internalization.
Discussion
Riboflavin (RF), commonly referred to as vitamin B2, critically influences the redox status of cells via formation of its phosphorylated derivates FMN and FAD. Yet, information on the mechanism and process regulators defining the dietary absorption of this essential nutrient remains sparse. Consequently, this lack of understanding provides the impetus to delineate the elements that mediate RF uptake especially in conditions exhibiting enhanced nutritional requirements such as pregnancy and tumors, which may be further exploited with diagnostic and therapeutic strategies.
Recent studies from our laboratory have indicated a receptor mediated endocytic mechanism of riboflavin transport in human intestinal and placental cells (Huang and Swaan, 2000; Huang and Swaan, 2001; Huang et al., 2003) . In this study, we examine the role of protein chaperones that aid RF endocytosis specific to its recognition and sequestration, followed by cell surface binding and internalization in mammalian cells. The well-studied chicken riboflavin carrier protein (cRCP) functions to bind and transport RF. Several laboratories have deduced its presence in mammalian species based on the evolutionary conserved protein domains (Foraker et al., 2003) , but a purified human form of the ligand-specific carrier protein presently remains elusive. Here, we demonstrate that human placental trophoblasts depend critically on such a RFspecific carrier protein (RCP) for cellular RF uptake since immunological inhibition with antibodies raised against the chicken RCP results in a total loss of RF accumulation. Indirect immunofluorescence shows that RCP is localized intracellularly in BeWo cells ( Figure 1D ), leading us to believe that RCP is secreted by the cell to facilitate RF uptake. Furthermore, this human RCP found in trophoblasts exhibits distinct specificity towards its designated ligand (RF)
since cross-reactivity with folate, another water-soluble vitamin was not established ( Figure 1B ).
We next evaluated the mechanism underlying the role of RCP in binding RF and facilitating its internalization process. First, the use of cRCP in a mammalian system was validated by its specific interactions with RF following transfections using cRCP and cRCP-GFP constructs (Figure 2) . We then radiolabeled the apo-form of cRCP to serve as a detectable marker and confirmed that these chemical modifications do not interfere with substrate recognition and binding to its interacting receptor(s) in BeWo cells, as well as in chicken hepatocytes (LMH/2A) that functioned as a species-specific control. Kinetic elucidation of cellular cRCP uptake revealed a saturable process with nanomolar affinities for the integral membrane receptor(s) (Table 1, Figure 3B ), which is in accordance with previous kinetic data of RF from our laboratory (Huang and Swaan, 2001) . Based on the aforementioned findings, we
propose that RCP serves to sequester its ligand from the extracellular medium and then traverses the membrane barrier with or without the attached cargo.
Differential transport capacities exhibited by the hepatocytes and trophoblasts may be attributed to differences in endogenous RCP expression and membrane interactions with RF or differences in the expression and interaction with unidentified cell surface receptor(s). Although specific RF or RCP receptors have yet to be identified in humans, prior reports allude to cRCP binding with lipoprotein receptors on oocyte membranes (Mac Lachlan et al., 1994) . Hence, we sought to examine the role of mutiligand-specific apical endocytic receptors belonging to the lipoprotein receptor superfamily, cubilin and megalin (Christensen and Birn, 2002) , in RCP-RF internalization. Seemingly, these receptors although expressed in trophoblasts do not influence the entry mechanism of RF (data not shown), which suggests that RCP-RF must react with a specific membrane RF receptor to complete the endocytic process. Another possibility that needs to be considered is perhaps the dual role of RCPs that function to sequester the ligand and then dock into the membrane to serve as the RF-receptor.
Visualization of rhodamine-labeled RF by immunofluorescence microscopy coupled with colocalization studies using endosomal and lysosomal markers supports the premise for endocytic mode of ligand entry in human placental cells (Huang et al., 2003) . Given that RCP associates with the ligand, RF and is then co-internalized, we evaluated the intracellular trafficking profile for the carrier-RF complex. Interestingly, subcellular distribution profiles of RCP within endosomes and lysosomes paralleled those of RF, although intracellular RF concentrations were significantly higher ( Figure 4 ). This may result from increased rates of RCP degradation and/or recycling to the extracellular environment to acquire additional cargo. This mechanism is analogous to the well-characterized transferrin receptor (TFR), which is endocytosed with its ligand (transferrin, TF) via clathrin-coated pits. TF remains associated with its receptor (TFR) until it recycles to the plasma membrane at which point dissociation takes place (van Dam et al., 2002) . This process distinguishes the TF-TFR complex from other lysosome-targeted proteins.
Co-administration of monensin in BeWo cells resulted in a significant decline of internalized 125 I-cRCP. Consequently, the bulk of radiolabeled protein remained associated with the plasma membrane, indicating a potential use for RCP in subsequent ligand interactions.
Similar observations have been reported for asialoglycoproteins (Harford et al., 1983) and proteoglycans, (Yanagishita and Hascall, 1985) , where degradation and accumulation of ligandreceptor complexes inside the cell is retarded in the presence of monensin. Furthermore, at and below physiologically relevant temperatures, the depot of internalized RCP that escapes degradation is subject to recycling as intact protein that contributes to the continued cycle of specific ligand recognition and uptake. Importantly, at normal physiological temperature (37 °C)
we observe increased recycling of RCP, suggesting that some protein may escape lysosomal degradation,and cycle back to the extracellular milieu where it is free to bind free RF.
In summary, our experiments demonstrate the presence of a riboflavin carrier protein in human placental trophoblasts that specifically binds its ligand. RF-associated RCP is then recognized by specific membrane binding partners and is taken up into the cells via previously hypothesized endocytic machinery. Internalized RCP trafficks within the cell and is ultimately either degraded in the lysosomes or is preserved to recycle back to the surface to scavenge additional cargo. Clearly, the identity of RCP and its receptor need further characterization.
Future studies utilizing proteomic tools are aimed at the isolation and identification of RCP and the interacting receptors, which will aid structural and molecular elucidation of the endocytic events. Cumulative recycled amounts are depicted as a function of time. 
